Success Metrics

Active Trials
3(60%)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_3
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Other(2)

Detailed Status

unknown2
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 31 (50.0%)
N/A1 (50.0%)

Trials by Status

unknown240%
active_not_recruiting120%
recruiting240%

Recent Activity

3 active trials
Showing 5 of 5
active_not_recruitingnot_applicable

Pulsed-field Ablation in Patients With Persistent Atrial Fibrillation

NCT05922917
recruiting

Left Atrial Posterior Wall and Mitral Isthmus PF Ablation in Non-Paroxysmal AF Patients

NCT06801392
recruitingphase_3

Pulsed-field Ablation Vs. Sham Ablation to Treat AF

NCT05717725
unknown

Renal Function and Hemolysis After Pulsed-field Ablation for Atrial Fibrillation

NCT06198933
unknown

Hemolysis During Pulsed-field and Radiofrequency Ablation

NCT06096428

Clinical Trials (5)

Showing 5 of 5 trials
NCT05922917Not Applicable

Pulsed-field Ablation in Patients With Persistent Atrial Fibrillation

Active Not Recruiting
NCT06801392

Left Atrial Posterior Wall and Mitral Isthmus PF Ablation in Non-Paroxysmal AF Patients

Recruiting
NCT05717725Phase 3

Pulsed-field Ablation Vs. Sham Ablation to Treat AF

Recruiting
NCT06198933

Renal Function and Hemolysis After Pulsed-field Ablation for Atrial Fibrillation

Unknown
NCT06096428

Hemolysis During Pulsed-field and Radiofrequency Ablation

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5